ELEFTHERIOS GEORGAKOPOULOS
Neurophysiologist-Genetics
Dr. Georgakopoulos is one of the world’s leading scientists in the field of genetics and molecular biology, with a huge scientific and research work and numerous distinctions.
He specialized in genetics by the eminent Professor of the University of Heidelberg K.-H. Matzura and Neurophysiology by the distinguished Professor of the Medical School of the same University, M. Zimmerman.
He is a member of the New York Academy of Sciences, and has collaborated research and scientifically in the field of medicine and biology. He collaborated for 3 years with Carlos Cordon Cardo, a distinguished scientist for his research in various fields.
Dr. Georgakopoulos has been active, among others, in the fields of biotechnology, molecular diagnosis, nanobiotechnology and molecular applications. He holds 17 national and international patents and has been awarded numerous national and international awards.
During his scientific career he founded and organized the Molecular Biology and Genetics Department at the Athens Medical Center, where he developed special activity with the execution of 5 research projects on epithelial cancer and the possibility of early diagnosis of micrometastatic disease in epithelial cancers.
He was CEO and CSO Acrogenomics Inc. listed on the New York NASDAQ Stock Exchange, dealing with genetics and nanotechnology. The company’s research project aimed at developing nanoparticles and identifying their properties for use in clinical applications.
In 2008 he took over the management of the stem cell quality system of Hygeia group.
With respect to the human, we investigate the uniqueness of its genetic material and its function.
At FGA Center we provide the special care and attention that the unique profile of each person requires. Our aim is to identify those mechanisms that effect and affect the general biological state of the organism.
Functional Genomics in this multifactorial event is the necessary tool for the investigation of pathological as well as pathophysiological conditions due to the fact that all human illnesses are polygenetic.
Polygenetic mean that a large number of genes and their products are involved in the origin and development of any traits and/or disease. These genes are found in different gene loci and at the same time spread to different chromosomes of our genome.
This type of heredity pattern includes many possible phenotypes determined by interactions between multiple alleles. Hair color, skin color, eye color, height, weight, metabolic syndrome, etc., are all examples of multi-genetic characteristics.
A number of different genotypes result from polygenic characteristics consisting of various combinations of dominant and recessive alleles. Thus:
- Individuals who inherit only dominant alleles will have a strong expression of the dominant phenotype.
- People who do not inherit dominant alleles will have a strong expression of the residual phenotype.
- Individuals who inherit different combinations of dominant and recessive alleles will exhibit different degrees of the intermediate phenotype.
The investigation through functional genomics includes the analysis and certification of Mononucleotide Polymorphisms (SNP’s)of many genes involved and characterized for various pathological and pathological conditions and the analysis and qualification of Single Nucleotide Polymorphisms (SNP’s) of cytochrome P450 genes (mitochondria function).
Part of functional genomics is Biochemical Genetic – Metabolomics: the metabolites are closely related to the phenotypes of living organisms and provide information on biochemical activities of the cellular metabolism.
Based on the results of the biochemical genetics, of the specialized metabolites, of the gene single mononucleotide polymorphisms of numerous of genes involved and characterized for pathological and pathophysiological conditions and the analysis and qualification of Single Nucleotide Polymorphisms (SNP’s) of cytochrome P450 genes (mitochondria function), specialized and personalized nutritional supplements are recommended and administered.
Today, personalized research is for us the only strategy, so that we can offer, through the synthesis – which for each person is unique – genetics, epigenomics, but also metabolites, the inspiration that will lead to a change in lifestyle, a better quality of life and ultimately to ‘well-being’